Science Explorer Back to mapMap
Discussion
Company · San Carlos · United States

Allakos (United States)

allakos.comROR OpenAlex
Research works
29
▼ 2% vs 2018-21
Citations
527
18.2 per fractional work
Top-10% rate
20.5%
all institutions 10.0%
Open access
54%
world 40%
International
13%
world 18%
Allakos (United States)

Not ranked overall: Allakos (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Allakos (United States) work in?

In all years, 71% of research at Allakos (United States) is in Health Sciences, 25% in Life Sciences. Its largest fields are Medicine (71%), Immunology and Microbiology (19%), Biochemistry, Genetics and Molecular Biology (5%). It does 2.4× the world's share of Health Sciences.

Health Sciences: 21 fractional works · 71.5% of its workMedicine: 21 fractional works · 71.5% of its workSurgery: 5 fractional works · 18.7% of its workRheumatology: 4 fractional works · 14.3% of its workPhysiology: 3 fractional works · 10.1% of its workDermatology: 2 fractional works · 7.6% of its workImmunology and Allergy: 2 fractional works · 6.1% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 3.8% of its workEpidemiology: 1 fractional works · 3.6% of its workPathology and Forensic Medicine: 1 fractional works · 2.0% of its workInfectious Diseases: 0 fractional works · 1.5% of its workOncology: 0 fractional works · 1.1% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.6% of its workGastroenterology: 0 fractional works · 0.4% of its workGenetics: 0 fractional works · 0.4% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.8% of its workLife Sciences: 7 fractional works · 24.8% of its workImmunology and Microbiology: 5 fractional works · 18.8% of its workImmunology: 5 fractional works · 18.8% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 5.2% of its workMolecular Biology: 1 fractional works · 5.2% of its workNeuroscience: 0 fractional works · 0.9% of its workSensory Systems: 0 fractional works · 0.9% of its workPhysical Sciences: 1 fractional works · 3.7% of its workChemistry: 1 fractional works · 2.9% of its workOrganic Chemistry: 1 fractional works · 2.9% of its workEnvironmental Science: 0 fractional works · 0.9% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.9% of its workALL ITS WORKAllakos (UnitedStates)29fractional works, all years
Life Sciences25%Physical Sciences4%Health Sciences71%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 6 fields, with their numbers
    1. Medicine2171.5%
    1. Immunology and Microbiology518.8%
    2. Biochemistry, Genetics and Molecular Biology15.2%
    3. Neuroscience00.9%
    1. Chemistry12.9%
    2. Environmental Science00.9%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Allakos (United States)?

Ranked on the quality score, Henrik Sandvad Rasmussen, Nenad Tomašević and Bradford A. Youngblood lead among researchers whose main affiliation is Allakos (United States).

  1. 1 Henrik Sandvad Rasmussen United States · #428,676 worldwide 7.9k citations · 186 works
  2. 2 Nenad Tomašević United States · #453,057 worldwide 2.7k citations · 47 works
  3. 3 Bradford A. Youngblood United States · #533,766 worldwide 1.2k citations · 55 works
  4. 4 Christopher R. Bebbington United States · #685,507 worldwide 2.2k citations · 48 works
  5. 5 Alan T. Chang United States · #722,449 worldwide 853 citations · 32 works
  6. 6 Emily C. Brock United States · #942,195 worldwide 852 citations · 29 works
  7. 7 Lauren Gehman United States · #951,837 worldwide 1.4k citations · 15 works
  8. 8 Julia Schanin United States · #1,474,055 worldwide 476 citations · 24 works
  9. 9 Bhupinder Singh United States · #1,591,678 worldwide 1.7k citations · 121 works
  10. 10 Alan Xu United States · #1,650,914 worldwide 605 citations · 15 works
All ranked researchers at Allakos (United States)

What are the most cited papers from Allakos (United States)?

The most cited paper from Allakos (United States) is "Anti–Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis" (Evan S. Dellon et al., 2020), with 269 citations. Next come "Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody" (111) and "AK002, a Humanized Sialic Acid-Binding Immunoglobulin-Like Lectin-8 Antibody that Induces Antibody-Dependent Cell-Mediated Cytotoxicity against Human Eosinophils and Inhibits Mast Cell-Mediated Anaphylaxis in Mice" (111).

Most cited papers
#PaperReleasedCitations
1 Anti–Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis Evan S. Dellon et al. · New England Journal of Medicine Open access 21 Oct 2020 269
2 Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody Simon Gebremeskel, Julia Schanin, Krysta Mila Coyle et al. · Frontiers in Immunology Open access 10 Mar 2021 111
3 AK002, a Humanized Sialic Acid-Binding Immunoglobulin-Like Lectin-8 Antibody that Induces Antibody-Dependent Cell-Mediated Cytotoxicity against Human Eosinophils and Inhibits Mast Cell-Mediated Anaphylaxis in Mice Bradford A. Youngblood, Emily C. Brock, John W. Leung et al. · International Archives of Allergy and Immunology Open access 2019 111
4 Siglec-8 antibody reduces eosinophils and mast cells in a transgenic mouse model of eosinophilic gastroenteritis Bradford A. Youngblood, Emily C. Brock, John W. Leung et al. · JCI Insight Open access 29 Aug 2019 106
5 An open-label, proof-of-concept study of lirentelimab for antihistamine-resistant chronic spontaneous and inducible urticaria Sabine Altrichter, Petra Staubach, MUHAMMAD N PASHA et al. · Journal of Allergy and Clinical Immunology Open access 23 Dec 2021 104
All 63 most cited papers, with filters and sorting

Which keywords describe research at Allakos (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Diagnosis, Treatment, Management, Inflammation, Children, Adults and Guidelines.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 33 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 33 words, with their numbers
  1. Epidemiology12▲ 9.9×15 topics
  2. Diagnosis9▲ 29×8 topics
  3. Treatment8▲ 22×4 topics
  4. Management8▲ 36×4 topics
  5. Inflammation8▲ 11×7 topics
  6. Children6▲ 85×3 topics
  7. Adults5▲ 254×2 topics
  8. Eosinophilic Esophagitis5▲ 621×1 topic
  9. Guidelines5▲ 38×2 topics
  10. Histologic Remission5▲ 621×1 topic
  11. Asthma4▲ 103×3 topics
  12. Allergic Disease4▲ 511×1 topic
  13. Mast Cells4▲ 511×1 topic
  14. Allergic Diseases3▲ 129×1 topic
  15. Eosinophils3▲ 129×1 topic
  16. Quality of Life3▲ 6.9×3 topics
  17. Filaggrin2▲ 182×1 topic
  18. Skin Microbiome2▲ 182×1 topic
  19. Autoantibodies2▲ 30×2 topics
  20. Autoimmune2▲ 138×2 topics
  21. Eosinophilia2▲ 131×2 topics
  22. Fusion Genes2▲ 269×1 topic
  23. Hypereosinophilic Syndrome2▲ 269×1 topic
  24. Cancer2▲ 4.9×6 topics
  25. Chronic Spontaneous Urticaria2▲ 287×1 topic
  26. Urticaria2▲ 287×1 topic
  27. Glycosylation2▲ 26×2 topics
  28. Monoclonal Antibodies1▲ 34×3 topics
  29. Therapeutic Antibodies1▲ 33×2 topics
  30. Antibody Engineering1▲ 37×1 topic
  31. Fc Receptors1▲ 37×1 topic
  32. IL-331▲ 241×1 topic
  33. Innate Lymphoid Cells1▲ 241×1 topic

Which research topics does Allakos (United States) publish most on?

By volume in 2022-now: Dermatology and Skin Diseases, Mast cells and histamine, Urticaria and Related Conditions and Asthma and respiratory diseases.

Dermatology and Skin Diseases: 2 fractional worksMast cells and histamine: 2 fractional worksUrticaria and Related Conditions: 2 fractional worksAsthma and respiratory diseases: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksEosinophilic Esophagitis1Eosinophilic Esophagitis: 1 fractional worksCarbohydrate Chemistry and Synthesis: 0 fractional worksIL-33, ST2, and ILC Pathways: 0 fractional worksEosinophilic Disorders and Syndromes: 0 fractional worksWhipple's Disease and Interleukins: 0 fractional works
DermatologyImmunologyRheumatologyPhysiology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Dermatology and Skin Diseases Dermatology 2 works
  2. 2 Mast cells and histamine Immunology 2 works
  3. 3 Urticaria and Related Conditions Rheumatology 2 works
  4. 4 Asthma and respiratory diseases Physiology 1 works
  5. 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  6. 6 Eosinophilic Esophagitis Surgery 1 works
  7. 7 Carbohydrate Chemistry and Synthesis Organic Chemistry 0 works
  8. 8 IL-33, ST2, and ILC Pathways Immunology 0 works
  9. 9 Eosinophilic Disorders and Syndromes Rheumatology 0 works
  10. 10 Whipple's Disease and Interleukins Pathology and Forensic Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available54.2%not open45.8%

World: 40% of research is openly available.

with international co-authors12.8%domestic only87.2%

World: 18% is written across borders.

How has Allakos (United States)'s research output changed?

Output in 2022-2025 was 2% lower than in 2018-2021.

20152020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Allakos (United States) as a percentage of every work published that year, 0.000087% in 2023.

0.000050%0.00010%0.00015%Allakos (United States)0.000048% in 20242020

Fractional works of Allakos (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in San Carlos

All research institutions in San Carlos

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Allakos (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.